Evidence map›Paper›PMID 24657450›Full record

ArticlePain2014

The VGF-derived peptide TLQP-21 contributes to inflammatory and nerve injury-induced hypersensitivity.

Carolyn A Fairbanks, Cristina D Peterson, Rebecca H Speltz, Maureen S Riedl, Kelley F Kitto, Jaclyn A Dykstra, Patrick D Braun, Masato Sadahiro, Stephen R Salton, Lucy Vulchanova

Open access · greenAbstract read
In one paragraph

Article in Pain, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. ACS nano · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Cytokines reprogram airway sensory neurons in asthma.bioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. The molecular identity of the TLQP-21 peptide receptor.Cellular and molecular life sciences : CMLS · 2021
    Review
  11. Article
  12. Article
  13. The VGF-derived Peptide TLQP21 Impairs Purinergic Control of Chemotaxis and Phagocytosis in Mouse Microglia.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. STIM Proteins and Orai CaFrontiers in pharmacology · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Carolyn A FairbanksDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, USA Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA Experimental and Clinical Pharmacology Graduate Program, University of Minnesota, Minneapolis, MN, USA Comparative and Molecular Biosciences Graduate Program, University of Minnesota, St. Paul, MN, USA Fishberg Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, MN, USA.
Cristina D Peterson
Rebecca H Speltz
Maureen S Riedl
Kelley F Kitto
Jaclyn A Dykstra
Patrick D Braun
Masato Sadahiro
Stephen R Salton
Lucy Vulchanova
University of Minnesota · USIcahn School of Medicine at Mount Sinai · US

Funding

VGF, critical role in the transition from acute to chronic painR01DE021996 · NIDCR · UNIVERSITY OF MINNESOTA · PI SALTON, STEPHEN R, VULCHANOVA, LYUDMILA H · 2011 to 2015
$2.4M
Comparative Medicine and Pathology TrainingT32RR018719 · NCRR · UNIVERSITY OF MINNESOTA TWIN CITIES · PI CARLSON, CATHY S. · 2003 to 2011
$2.2M
VGF function in depression and antidepressant treatmentR01MH086499 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SALTON, STEPHEN R · 2010 to 2014
$2.1M
Training Program in Mental Health ResearchT32MH096678 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SALTON, STEPHEN R, SHAPIRO, MATTHEW L · 2012 to 2016
$1.1M
The Neurosecretory Protein VGF: Contributions to PainR21DA025170 · NIDA · UNIVERSITY OF MINNESOTA · PI VULCHANOVA, LYUDMILA H · 2009 to 2010
$413k
Human VGF Polymorphisms and DepressionR33MH083496 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SALTON, STEPHEN R · 2010 to 2010
$254k
NCRR NIH HHS T32 RR018719NIDA NIH HHS R21 DA025170NIDCR NIH HHS R01 DE021996NIMH NIH HHS R01 MH086499NIMH NIH HHS R33 MH083496NIMH NIH HHS T32 MH096678
6 · The paper itself

Abstract

VGF (nonacronymic) is a granin-like protein that is packaged and proteolytically processed within the regulated secretory pathway. VGF and peptides derived from its processing have been implicated in neuroplasticity associated with learning, memory, depression, and chronic pain. In sensory neurons, VGF is rapidly increased following peripheral nerve injury and inflammation. Several bioactive peptides generated from the C-terminus of VGF have pronociceptive spinal effects. The goal of the present study was to examine the spinal effects of the peptide TLQP-21 and determine whether it participates in spinal mechanisms of persistent pain. Application of exogenous TLQP-21 induced dose-dependent thermal hyperalgesia in the warm-water immersion tail-withdrawal test. This hyperalgesia was inhibited by a p38 mitogen-activated protein kinase inhibitor, as well as inhibitors of cyclooxygenase and lipoxygenase. We used immunoneutralization of TLQP-21 to determine the function of the endogenous peptide in mechanisms underlying persistent pain. In mice injected intradermally with complete Freund adjuvant, intrathecal treatment with anti-TLQP-21 immediately prior to or 5hours after induction of inflammation dose-dependently inhibited tactile hypersensitivity and thermal hyperalgesia. Intrathecal anti-TL21 administration also attenuated the development and maintenance of tactile hypersensitivity in the spared nerve injury model of neuropathic pain. These results provide evidence that endogenous TLQP-21 peptide contributes to the mechanisms of spinal neuroplasticity after inflammation and nerve injury.

Indexed as

AnimalsCyclooxygenase InhibitorsDisease Models, AnimalFreund's AdjuvantHot TemperatureHyperalgesiaInflammationInjections, SpinalLipoxygenase InhibitorsMiceNerve Growth FactorsNeuralgiaNeuropeptidesNociceptionp38 Mitogen-Activated Protein KinasesPeptide FragmentsCyclooxygenase InhibitorsFreund's AdjuvantLipoxygenase InhibitorsNerve Growth FactorsNeuropeptidesp38 Mitogen-Activated Protein KinasesPeptide FragmentsTLQP-21 peptideVgf protein, mouseHyperalgesiaImmunoneutralizationInflammationNeuropathic painNeuropeptide

Identifiers

PMID24657450
PMCPMC4070220
OpenAlexW2102554343

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.